208 related articles for article (PubMed ID: 37047529)
41. The Senolytic Drug JQ1 Removes Senescent Cells via Ferroptosis.
Go S; Kang M; Kwon SP; Jung M; Jeon OH; Kim BS
Tissue Eng Regen Med; 2021 Oct; 18(5):841-850. PubMed ID: 34003467
[TBL] [Abstract][Full Text] [Related]
42. [Towards success against senescence?].
Jordan B
Med Sci (Paris); 2018 Oct; 34(10):885-890. PubMed ID: 30451682
[TBL] [Abstract][Full Text] [Related]
43. Chemoinformatic Screening for the Selection of Potential Senolytic Compounds from Natural Products.
Barrera-Vázquez OS; Gómez-Verjan JC; Magos-Guerrero GA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33809876
[TBL] [Abstract][Full Text] [Related]
44. Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells.
Rysanek D; Vasicova P; Kolla JN; Sedlak D; Andera L; Bartek J; Hodny Z
Aging (Albany NY); 2022 Aug; 14(16):6381-6414. PubMed ID: 35951353
[TBL] [Abstract][Full Text] [Related]
45. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
Shahbandi A; Rao SG; Anderson AY; Frey WD; Olayiwola JO; Ungerleider NA; Jackson JG
Cell Death Differ; 2020 Nov; 27(11):3097-3116. PubMed ID: 32457483
[TBL] [Abstract][Full Text] [Related]
46. Cellular senescence and its role in white adipose tissue.
Smith U; Li Q; Rydén M; Spalding KL
Int J Obes (Lond); 2021 May; 45(5):934-943. PubMed ID: 33510393
[TBL] [Abstract][Full Text] [Related]
47. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
Basisty N; Kale A; Patel S; Campisi J; Schilling B
Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
[TBL] [Abstract][Full Text] [Related]
48. AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe
Lewinska A; Adamczyk-Grochala J; Bloniarz D; Olszowka J; Kulpa-Greszta M; Litwinienko G; Tomaszewska A; Wnuk M; Pazik R
Redox Biol; 2020 Jan; 28():101337. PubMed ID: 31622846
[TBL] [Abstract][Full Text] [Related]
49. Flavonoids in Skin Senescence Prevention and Treatment.
Domaszewska-Szostek A; Puzianowska-Kuźnicka M; Kuryłowicz A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201952
[TBL] [Abstract][Full Text] [Related]
50. Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice.
Liu J; Zhang J; Lin X; Boyce BF; Zhang H; Xing L
J Clin Invest; 2022 Apr; 132(8):. PubMed ID: 35426372
[TBL] [Abstract][Full Text] [Related]
51. Targeting normal and cancer senescent cells as a strategy of senotherapy.
Sikora E; Bielak-Zmijewska A; Mosieniak G
Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
[TBL] [Abstract][Full Text] [Related]
52. Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.
Pignolo RJ; Samsonraj RM; Law SF; Wang H; Chandra A
Curr Osteoporos Rep; 2019 Apr; 17(2):70-85. PubMed ID: 30806947
[TBL] [Abstract][Full Text] [Related]
53. Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation.
Liu X; Wang Y; Zhang X; Gao Z; Zhang S; Shi P; Zhang X; Song L; Hendrickson H; Zhou D; Zheng G
Bioorg Med Chem; 2018 Aug; 26(14):3925-3938. PubMed ID: 29925484
[TBL] [Abstract][Full Text] [Related]
54. Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans.
Yamane M; Sato S; Shimizu E; Shibata S; Hayano M; Yaguchi T; Kamijuku H; Ogawa M; Suzuki T; Mukai S; Shimmura S; Okano H; Takeuchi T; Kawakami Y; Ogawa Y; Tsubota K
FASEB J; 2020 Aug; 34(8):10778-10800. PubMed ID: 32619061
[TBL] [Abstract][Full Text] [Related]
55. Senotherapeutics in Cancer and HIV.
Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
[TBL] [Abstract][Full Text] [Related]
56. Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells.
Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin I; Leonova K; Polinsky A; Chernova OB; Gudkov AV
Aging (Albany NY); 2016 Jul; 8(7):1294-315. PubMed ID: 27391570
[TBL] [Abstract][Full Text] [Related]
57. Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review.
Amaya-Montoya M; Pérez-Londoño A; Guatibonza-García V; Vargas-Villanueva A; Mendivil CO
Adv Ther; 2020 Apr; 37(4):1407-1424. PubMed ID: 32185730
[TBL] [Abstract][Full Text] [Related]
58. Senolytics and the compression of late-life mortality.
Kowald A; Kirkwood TBL
Exp Gerontol; 2021 Nov; 155():111588. PubMed ID: 34637949
[TBL] [Abstract][Full Text] [Related]
59. Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.
Cherif H; Bisson DG; Mannarino M; Rabau O; Ouellet JA; Haglund L
Elife; 2020 Aug; 9():. PubMed ID: 32821059
[TBL] [Abstract][Full Text] [Related]
60. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
